Risk-Based Therapy for Localized Osteosarcoma.

Item

http://www.wikidata.org/entity/Q41185936

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Risk-Based Therapy for Localized Osteosarcoma.

@en

type

Item

label

Risk-Based Therapy for Localized Osteosarcoma.

@en

prefLabel

Risk-Based Therapy for Localized Osteosarcoma.

@en

P1476

Risk-Based Therapy for Localized Osteosarcoma

@en

P2093

Ching Lau

http://www.w3.org/2001/XMLSchema#string

Eunji Jo

http://www.w3.org/2001/XMLSchema#string

Jeffrey Murray

http://www.w3.org/2001/XMLSchema#string

Lee Helman

http://www.w3.org/2001/XMLSchema#string

M John Hicks

http://www.w3.org/2001/XMLSchema#string

Murali Chintagumpala

http://www.w3.org/2001/XMLSchema#string

Rajkumar Venkatramani

http://www.w3.org/2001/XMLSchema#string

Robert Krance

http://www.w3.org/2001/XMLSchema#string

William Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. A Southwest Oncology Group study.

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

P304

412-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25808

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Murali Chintagumpala

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26501936

http://www.w3.org/2001/XMLSchema#string

P932

6993185

http://www.w3.org/2001/XMLSchema#string